PATENT CLAIM ANALYSIS

Application Number: 16419927
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "263400"]

Abstract:
The present invention relates to adenine which is useful to activate AMP-activated protein kinase (AMPK) and the use of adenine in the prevention or treatment of conditions or disease and thereby prevent or treat conditions or diseases which can be ameliorated by AMPK in a mammal.

Claim (Index 12):
A method for preventing or treating reactive oxygen species (ROS) associated condition or disease, comprising administrating to a mammal in need thereof with an effective amount of adenine and/or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 100.0
- Lexical Diversity: 1.32432
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13859741', '12901782', '13870350', '12470514', '13858954']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7202243615422708
- 35 USC 102 Novelty (BERT): 0.5349180276290908
- Combined Prediction Score: 0.7016937281509528
- Mean Citation Score: 203.817596
- Max Citation Score: 366.68628
- Similarity Product: 259.42537804152494

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test